SOLV
Income statement / Annual
Last year (2023), Solventum Corporation's total revenue was $8.20 B,
an increase of 0.82% from the previous year.
In 2023, Solventum Corporation's net income was $1.35 B.
See Solventum Corporation’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
Operating Revenue |
$8.20 B
|
$8.13 B
|
$8.17 B
|
$7.28 B
|
Cost of Revenue |
$3.68 B |
$3.44 B |
$3.25 B |
$2.97 B |
Gross Profit |
$4.52 B |
$4.70 B |
$4.92 B |
$4.32 B |
Gross Profit Ratio |
0.55 |
0.58 |
0.6 |
0.59 |
Research and Development
Expenses |
$758.00 M
|
$767.00 M
|
$766.00 M
|
$719.00 M
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$2.24 B
|
$2.24 B
|
$2.28 B
|
$2.17 B
|
Other Expenses |
$0.00 |
-$1.00 M |
$3.00 M |
$10.00 M |
Operating Expenses |
$3.00 B |
$3.00 B |
$3.04 B |
$2.89 B |
Cost And Expenses |
$6.51 B |
$6.44 B |
$6.29 B |
$5.85 B |
Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Depreciation &
Amortization |
$561.00 M
|
$578.00 M
|
$597.00 M
|
$599.00 M
|
EBITDA |
$2.25 B
|
$2.27 B
|
$2.48 B
|
$2.03 B
|
EBITDA Ratio |
0.27 |
0.28 |
0.3 |
0.28 |
Operating Income Ratio
|
0.21
|
0.21
|
0.23
|
0.2
|
Total Other
Income/Expenses Net |
-$25.00 M
|
-$1.00 M
|
$3.00 M
|
$10.00 M
|
Income Before Tax |
$1.67 B |
$1.69 B |
$1.88 B |
$1.44 B |
Income Before Tax Ratio
|
0.2
|
0.21
|
0.23
|
0.2
|
Income Tax Expense |
$321.00 M |
$349.00 M |
$422.00 M |
$302.00 M |
Net Income |
$1.35 B |
$1.34 B |
$1.46 B |
$1.14 B |
Net Income Ratio |
0.16 |
0.17 |
0.18 |
0.16 |
EPS |
7.8 |
7.79 |
8.47 |
6.6 |
EPS Diluted |
7.8 |
7.79 |
8.47 |
6.6 |
Weighted Average Shares
Out |
$172.47 M
|
$172.47 M
|
$172.47 M
|
$172.47 M
|
Weighted Average Shares
Out Diluted |
$172.47 M
|
$172.47 M
|
$172.47 M
|
$172.47 M
|
Link |
|
|
|
|